van Oort IM - Search Results

1

Identification of a Candidate Gene Panel for the Early Diagnosis of Prostate Cancer.

Leyten GH, Hessels D, Smit FP, Jannink SA, de Jong H, Melchers WJ, Cornel EB, de Reijke TM, Vergunst H, Kil P, Knipscheer BC, Hulsbergen-van de Kaa CA, Mulders PF, van Oort IM, Schalken JA. Leyten GH, et al. Among authors: van oort im. Clin Cancer Res. 2015 Jul 1;21(13):3061-70. doi: 10.1158/1078-0432.CCR-14-3334. Epub 2015 Mar 18. Clin Cancer Res. 2015. PMID: 25788493

2

Mapping European Association of Urology Guideline Practice Across Europe: An Audit of Androgen Deprivation Therapy Use Before Prostate Cancer Surgery in 6598 Cases in 187 Hospitals Across 31 European Countries.

MacLennan S, Azevedo N, Duncan E, Dunsmore J, Fullwood L, Lumen N, Plass K, Ribal MJ, Roobol MJ, Nieboer D, Schouten N, Skolarus TA, Smith EJ, N'Dow J, Mottet N, Briganti A; Pan-European National Urological Society IMAGINE Collaborative (see Supplemental material for group members affiliations):. MacLennan S, et al. Eur Urol. 2023 May;83(5):393-401. doi: 10.1016/j.eururo.2022.12.031. Epub 2023 Jan 11. Eur Urol. 2023. PMID: 36639296 Free article.

3

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer.

Hessels D, Klein Gunnewiek JM, van Oort I, Karthaus HF, van Leenders GJ, van Balken B, Kiemeney LA, Witjes JA, Schalken JA. Hessels D, et al. Eur Urol. 2003 Jul;44(1):8-15; discussion 15-6. doi: 10.1016/s0302-2838(03)00201-x. Eur Urol. 2003. PMID: 12814669

4

The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.

van Oort IM, Tomita K, van Bokhoven A, Bussemakers MJ, Kiemeney LA, Karthaus HF, Witjes JA, Schalken JA. van Oort IM, et al. Among authors: van bokhoven a. Prostate. 2007 Sep 15;67(13):1432-8. doi: 10.1002/pros.20626. Prostate. 2007. PMID: 17639504

5

Maximum tumor diameter is not an independent prognostic factor in high-risk localized prostate cancer.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-vandeKaa CA. van Oort IM, et al. World J Urol. 2008 Jun;26(3):237-41. doi: 10.1007/s00345-008-0242-7. Epub 2008 Feb 12. World J Urol. 2008. PMID: 18265988 Free PMC article.

6

The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.

van Oort IM, Witjes JA, Kok DE, Kiemeney LA, Hulsbergen-Van De Kaa CA. van Oort IM, et al. BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336608

7

A single institution experience with biochemical recurrence after radical prostatectomy for tumors that on pathology are of small volume or "insignificant".

van Oort IM, Kok DE, Kiemeney LA, Hulsbergen-van de Kaa CA, Witjes JA. van Oort IM, et al. Urol Oncol. 2009 Sep-Oct;27(5):509-13. doi: 10.1016/j.urolonc.2008.04.014. Epub 2008 Jul 14. Urol Oncol. 2009. PMID: 18625570

8

Thirty-two-channel coil 3T magnetic resonance-guided biopsies of prostate tumor suspicious regions identified on multimodality 3T magnetic resonance imaging: technique and feasibility.

Hambrock T, Fütterer JJ, Huisman HJ, Hulsbergen-vandeKaa C, van Basten JP, van Oort I, Witjes JA, Barentsz JO. Hambrock T, et al. Invest Radiol. 2008 Oct;43(10):686-94. doi: 10.1097/RLI.0b013e31817d0506. Invest Radiol. 2008. PMID: 18791410

9

Body mass index as a prognostic marker for biochemical recurrence in Dutch men treated with radical prostatectomy.

van Roermund JG, Kok DE, Wildhagen MF, Kiemeney LA, Struik F, Sloot S, van Oort IM, Hulsbergen-van de Kaa CA, van Leenders GJ, Bangma CH, Witjes JA. van Roermund JG, et al. Among authors: van oort im, van leenders gj. BJU Int. 2009 Aug;104(3):321-5. doi: 10.1111/j.1464-410X.2009.08404.x. Epub 2009 Feb 11. BJU Int. 2009. PMID: 19220264

10

Feasibility of 3T dynamic contrast-enhanced magnetic resonance-guided biopsy in localizing local recurrence of prostate cancer after external beam radiation therapy.

Yakar D, Hambrock T, Huisman H, Hulsbergen-van de Kaa CA, van Lin E, Vergunst H, Hoeks CM, van Oort IM, Witjes JA, Barentsz JO, Fütterer JJ. Yakar D, et al. Among authors: van lin e, van oort im. Invest Radiol. 2010 Mar;45(3):121-5. doi: 10.1097/RLI.0b013e3181c7bcda. Invest Radiol. 2010. PMID: 20065860

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

168 results

Search Page

Filters